Back
RxSight, Inc. 10K Form
Sell
8
RXST
RxSight, Inc.
Last Price:
$7.62
Seasonality Move:
12.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RXST News And Ratings
See the #1 stock for the next 7 days that we like better than RXST
RXST Financial Statistics
Sales & Book Value
| Annual Sales: | $134.5M |
|---|---|
| Cash Flow: | $-2.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.68 |
| Price / Book: | 1.14 |
Profitability
| EPS (TTM): | -0.95340 |
|---|---|
| Net Income (TTM): | $-38.9M |
| Gross Margin: | $103M |
| Return on Equity: | -14.01% |
| Return on Assets: | -12.43% |
RxSight, Inc. Earnings Forecast
Key RxSight, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for RXST is 76.60%.
-
The Selling, General & Administrative Expenses for RXST have been equal to 83.77% of Gross Profit Margin.
-
The Research & Development expenses have been 28.67% of Revenue.
-
The Net Earning history of RXST is -28.96% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 2 years.
RxSight, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | RXST |
| Website: | rxsight.com/ |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 10.95 |
| Quick Ratio: | 9.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 179.01 |
RXST Technical Analysis vs Fundamental Analysis
Sell
8
RxSight, Inc. (RXST)
is a Sell
Is RxSight, Inc. a Buy or a Sell?
-
RxSight, Inc. stock is rated a SellThe current RxSight, Inc. [RXST] share price is $7.61. The Score for RXST is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.